Surgical Simulation Market

Publisher Grand View Research

Published Mar 30, 2026

Length 150 Pages

SKU # GV21085421

Description

Surgical Simulation Market Size, Share & Trends Analysis Report By Specialty, By Material (Virtual Patient Simulation, 3D Printing), By End Use (Academic Institutes, Hospitals), By Region, And Segment Forecasts, 2026 - 2033

Surgical Simulation Market Summary

The global surgical simulation market size was estimated at USD 530.73 million in 2025 and is projected to reach USD 1,804.38 million by 2033, growing at a CAGR of 16.57% from 2026 to 2033. Market growth is driven by advancements in medical technology, increasing demand for minimally invasive procedures, and a focus on enhancing surgical training and patient safety.

Safe surgical care is a critical yet often overlooked component of health systems, with around 5 billion people lacking access. According to the Lancet Commission on Global Surgery 2030, only 6% of global surgeries are performed in the poorest nations, which account for one-third of the world’s population. A major issue is workforce training; low- and middle-income countries (LMICs) face severe shortages of certified surgeons, posing significant barriers to care. The global shortage of skilled surgeons, combined with the increasing complexity of surgeries, has intensified the need for advanced training tools that simulate real-life scenarios.

The Lancet Commission recommends expanding the surgical, anesthetic, and obstetric workforce in LMICs to 40 per 100,000 people by 2030. However, traditional training in high-income countries can take over seven years, with up to 30% of trainees reporting a lack of readiness for independent practice post-residency. This gap in surgical education is driving the demand for surgical simulation solutions to improve workforce readiness and patient outcomes.

Technological advancements in the market, such as Virtual Reality (VR), have improved accessibility and reduced hardware costs, overcoming key adoption barriers. For instance, in November 2023, Simulare Medical announced the launch of its Alveolar Bone Graft (ABG) simulator, a novel addition to its expanding portfolio of high-fidelity surgical simulators designed for cleft surgery training.

Similarly, research by Vantari VR in June 2022 found that their medical VR training programs lowered medical errors by 40%. In addition, a University of Wollongong study conducted with Vantari VR reported a 32% improvement in student clinician performance and a 39% boost in adherence to safety and hygiene protocols. These results underscore VR technology’s significant potential to enhance surgical education and improve patient care outcomes.

Global Surgical Simulation Market Report Segmentation

This report forecasts revenue growth and provides, at the regional and country level, an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global surgical simulation market based on specialty, technology, end use, and region:

Specialty Outlook (Revenue, USD Million, 2021 - 2033)
Cardiac Surgery
Gastroenterology
Neurosurgery
Orthopedic Surgery
Reconstructive Surgery
Oncology Surgery
Transplant
Others
Technology Outlook (Revenue, USD Million, 2021 - 2033)
Virtual Patient Simulation
3D Printing
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Academic Institutes
Hospitals
Military Organizations
Research Organizations
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation & Scope; 1.1.1. Specialty; 1.1.2. Technology; 1.1.3. End Use; 1.1.4. Estimates and forecast timeline.; 1.2. Research Methodology; 1.3. Information Procurement; 1.3.1. Purchased database.; 1.3.2. GVR’s internal database; 1.3.3. Secondary sources; 1.3.4. Primary research; 1.3.5. Details of primary research; 1.4. Information or Data Analysis; 1.4.1. Data analysis models; 1.5. Market Formulation & Validation; 1.6. Model Details; 1.6.1. Commodity flow analysis (Model 1); 1.6.2. Approach 1: Commodity flow approach; 1.6.3. Approach 2: Volume Analysis; 1.7. List of Secondary Sources; 1.8. List of Primary Sources; 1.9. Objectives
Chapter 2. Executive Summary: 2.1. Market Outlook; 2.2. Segment Outlook; 2.2.1. Specialty Outlook; 2.2.2. Technology Outlook; 2.2.3. End Use Outlook; 2.3. Competitive Insights
Chapter 3. Surgical Simulation Market Variables, Trends & Scope: 3.1. Market Lineage Outlook; 3.1.1. Parent market outlook; 3.1.2. Related/ancillary market outlook; 3.2. Market Dynamics; 3.2.1. Market driver analysis; 3.2.1.1. Advancements in medical technology; 3.2.1.2. Growing demand for minimally invasive surgeries; 3.2.1.3. Rising focus on patient safety and error reduction; 3.2.1.4. Focus on enhancing surgical training; 3.2.1.5. Shortage of skilled healthcare professionals; 3.2.2. Market restraint analysis; 3.2.2.1. High cost of simulators; 3.2.2.2. Limited adoption in developing healthcare systems; 3.2.2.3. Lack of standardization in simulation-based training; 3.2.3. Market opportunity analysis; 3.2.3.1. Expansion of Healthcare Infrastructure and Training Centers; 3.2.4. Market challenges analysis; 3.3. Technology Overview; 3.3.1.1. Virtual Reality (VR); 3.3.1.2. Augmented Reality (AR); 3.3.1.3. Virtual Patient Simulation; 3.3.1.4. Artificial Intelligence (AI); 3.4. Surgical Simulation Market Analysis Tools; 3.4.1. Industry Analysis - Porter’s; 3.4.1.1. Supplier power; 3.4.1.2. Buyer power; 3.4.1.3. Substitution threat; 3.4.1.4. Threat of new entrant; 3.4.1.5. Competitive rivalry; 3.4.2. PESTEL Analysis; 3.4.2.1. Political landscape; 3.4.2.2. Economic landscape; 3.4.2.3. Social landscape; 3.4.2.4. Technological landscape; 3.4.2.5. Environmental landscape; 3.4.2.6. Legal landscape; 3.5. Case Studies & Insights
Chapter 4. Surgical Simulation Market: Specialty Estimates & Trend Analysis: 4.1. Specialty Market Share, 2025 & 2033; 4.2. Segment Dashboard; 4.3. Surgical Simulation Market by Specialty Outlook; 4.4. Cardiac Surgery; 4.4.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.5. Gastroenterology; 4.5.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.6. Neurosurgery; 4.6.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.7. Orthopedic Surgery; 4.7.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.8. Reconstructive Surgery; 4.8.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.9. Oncology Surgery; 4.9.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.10. Transplant; 4.10.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.11. Others; 4.11.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 5. Surgical Simulation Market: Technology Estimates & Trend Analysis: 5.1. Technology Market Share, 2025 & 2033; 5.2. Segment Dashboard; 5.3. Surgical Simulation Market by Technology Outlook; 5.4. Virtual Patient Simulation; 5.4.1. Market estimates and forecast 2021 - 2033 (USD Million); 5.5. 3D Printing; 5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 6. Surgical Simulation Market: End Use Estimates & Trend Analysis: 6.1. End Use Market Share, 2025 & 2033; 6.2. Segment Dashboard; 6.3. Surgical Simulation Market by End Use Outlook; 6.4. Academic Institutes; 6.4.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.5. Hospitals; 6.5.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.6. Military Organizations; 6.6.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.7. Research Organizations; 6.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 7. Surgical Simulation Market: Regional Estimates & Trend Analysis, By Type: 7.1. Regional Market Share Analysis, 2025 & 2033; 7.2. Regional Market Dashboard; 7.3. Global Regional Market Snapshot; 7.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:; 7.5. North America; 7.5.1. U.S.; 7.5.1.1. Key country dynamics; 7.5.1.2. Regulatory framework; 7.5.1.3. Competitive scenario; 7.5.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million); 7.5.2. Canada; 7.5.2.1. Key country dynamics; 7.5.2.2. Regulatory framework; 7.5.2.3. Competitive scenario; 7.5.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million); 7.5.3. Mexico; 7.5.3.1. Key country dynamics; 7.5.3.2. Regulatory framework; 7.5.3.3. Competitive scenario; 7.5.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million); 7.6. Europe; 7.6.1. UK; 7.6.1.1. Key country dynamics; 7.6.1.2. Regulatory framework; 7.6.1.3. Competitive scenario; 7.6.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million); 7.6.2. Germany; 7.6.2.1. Key country dynamics; 7.6.2.2. Regulatory framework; 7.6.2.3. Competitive scenario; 7.6.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million); 7.6.3. France; 7.6.3.1. Key country dynamics; 7.6.3.2. Regulatory framework; 7.6.3.3. Competitive scenario; 7.6.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million); 7.6.4. Italy; 7.6.4.1. Key country dynamics; 7.6.4.2. Regulatory framework; 7.6.4.3. Competitive scenario; 7.6.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million); 7.6.5. Spain; 7.6.5.1. Key country dynamics; 7.6.5.2. Regulatory framework; 7.6.5.3. Competitive scenario; 7.6.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million); 7.6.6. Denmark; 7.6.6.1. Key country dynamics; 7.6.6.2. Regulatory framework; 7.6.6.3. Competitive scenario; 7.6.6.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million); 7.6.7. Sweden; 7.6.7.1. Key country dynamics; 7.6.7.2. Regulatory framework; 7.6.7.3. Competitive scenario; 7.6.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million); 7.6.8. Norway; 7.6.8.1. Key country dynamics; 7.6.8.2. Regulatory framework; 7.6.8.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million); 7.7. Asia Pacific; 7.7.1. Japan; 7.7.1.1. Key country dynamics; 7.7.1.2. Regulatory framework; 7.7.1.3. Competitive scenario; 7.7.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million); 7.7.2. China; 7.7.2.1. Key country dynamics; 7.7.2.2. Regulatory framework; 7.7.2.3. Competitive scenario; 7.7.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million); 7.7.3. India; 7.7.3.1. Key country dynamics; 7.7.3.2. Regulatory framework; 7.7.3.3. Competitive scenario; 7.7.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million); 7.7.4. Australia; 7.7.4.1. Key country dynamics; 7.7.4.2. Regulatory framework; 7.7.4.3. Competitive scenario; 7.7.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million); 7.7.5. South Korea; 7.7.5.1. Key country dynamics; 7.7.5.2. Regulatory framework; 7.7.5.3. Competitive scenario; 7.7.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million); 7.7.6. Thailand; 7.7.6.1. Key country dynamics; 7.7.6.2. Regulatory framework; 7.7.6.3. Competitive scenario; 7.7.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million); 7.8. Latin America; 7.8.1. Brazil; 7.8.1.1. Key country dynamics; 7.8.1.2. Regulatory framework; 7.8.1.3. Competitive scenario; 7.8.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million); 7.8.2. Argentina; 7.8.2.1. Key country dynamics; 7.8.2.2. Regulatory framework; 7.8.2.3. Competitive scenario; 7.8.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million); 7.9. MEA; 7.9.1. South Africa; 7.9.1.1. Key country dynamics; 7.9.1.2. Regulatory framework; 7.9.1.3. Competitive scenario; 7.9.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million); 7.9.2. Saudi Arabia; 7.9.2.1. Key country dynamics; 7.9.2.2. Regulatory framework; 7.9.2.3. Competitive scenario; 7.9.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million); 7.9.3. UAE; 7.9.3.1. Key country dynamics; 7.9.3.2. Regulatory framework; 7.9.3.3. Competitive scenario; 7.9.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million); 7.9.4. Kuwait; 7.9.4.1. Key country dynamics; 7.9.4.2. Regulatory framework; 7.9.4.3. Competitive scenario; 7.9.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape: 8.1. Recent Developments & Impact Analysis, By Key Market Participants; 8.2. Company/Competition Categorization; 8.3. Key Company Market Share/Position Analysis, 2025; 8.4. Company Profiles; 8.4.1. Materialise; 8.4.1.1. Company overview; 8.4.1.2. Financial performance; 8.4.1.3. Product benchmarking; 8.4.1.4. Strategic initiatives; 8.4.2. Stratasys; 8.4.2.1. Company overview; 8.4.2.2. Financial performance; 8.4.2.3. Product benchmarking; 8.4.2.4. Strategic initiatives; 8.4.3. Surgical Science; 8.4.3.1. Company overview; 8.4.3.2. Financial performance; 8.4.3.3. Product benchmarking; 8.4.3.4. Strategic initiatives; 8.4.4. Mentice; 8.4.4.1. Company overview; 8.4.4.2. Financial performance; 8.4.4.3. Product benchmarking; 8.4.4.4. Strategic initiatives; 8.4.5. Gaumard Scientific; 8.4.5.1. Company overview; 8.4.5.2. Financial performance; 8.4.5.3. Product benchmarking; 8.4.5.4. Strategic initiatives; 8.4.6. Simulab Corporation; 8.4.6.1. Company overview; 8.4.6.2. Financial performance; 8.4.6.3. Product benchmarking; 8.4.6.4. Strategic initiatives; 8.4.7. VirtaMed AG; 8.4.7.1. Company overview; 8.4.7.2. Financial performance; 8.4.7.3. Product benchmarking; 8.4.7.4. Strategic initiatives; 8.4.8. 3-Dmed Learning Through Simulation; 8.4.8.1. Company overview; 8.4.8.2. Financial performance; 8.4.8.3. Product benchmarking; 8.4.8.4. Strategic initiatives; 8.4.9. Laerdal Medical; 8.4.9.1. Company overview; 8.4.9.2. Financial performance; 8.4.9.3. Product benchmarking; 8.4.9.4. Strategic initiatives; 8.4.10. 3D Systems, Inc.; 8.4.10.1. Company overview; 8.4.10.2. Financial performance; 8.4.10.3. Product benchmarking; 8.4.10.4. Strategic initiatives; 8.4.11. Osteo3d; 8.4.11.1. Company overview; 8.4.11.2. Financial performance; 8.4.11.3. Product benchmarking; 8.4.11.4. Strategic initiatives; 8.4.12. AXIAL3D; 8.4.12.1. Company overview; 8.4.12.2. Financial performance; 8.4.12.3. Product benchmarking; 8.4.12.4. Strategic initiatives; 8.4.13. Formlabs; 8.4.13.1. Company overview; 8.4.13.2. Financial performance; 8.4.13.3. Product benchmarking; 8.4.13.4. Strategic initiatives; 8.4.14. Kyoto Kagaku Co., Ltd.; 8.4.14.1. Company overview; 8.4.14.2. Financial performance; 8.4.14.3. Product benchmarking; 8.4.14.4. Strategic initiatives; 8.4.15. CAE Inc.; 8.4.15.1. Company overview; 8.4.15.2. Financial performance; 8.4.15.3. Product benchmarking; 8.4.15.4. Strategic initiatives

Pricing

Currency Rates

Single User Email from Publisher $5,950
Multi License Fulfilled by Publisher $6,950
Global Site License Email from Publisher $8,950

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now